- Home
- LVTX vs SRZN Comparison
LVTX vs SRZN Comparison
Compare LVTX & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVTX
- SRZN
- Stock Information
- Founded
- LVTX 2016
- SRZN 2015
- Country
- LVTX Netherlands
- SRZN United States
- Employees
- LVTX N/A
- SRZN N/A
- Industry
- LVTX Biotechnology: Pharmaceutical Preparations
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- LVTX Health Care
- SRZN Health Care
- Exchange
- LVTX Nasdaq
- SRZN Nasdaq
- Market Cap
- LVTX 27.9M
- SRZN 33.0M
- IPO Year
- LVTX 2021
- SRZN N/A
- Fundamental
- Price
- LVTX $0.96
- SRZN $11.20
- Analyst Decision
- LVTX Buy
- SRZN Strong Buy
- Analyst Count
- LVTX 3
- SRZN 2
- Target Price
- LVTX $3.33
- SRZN $38.50
- AVG Volume (30 Days)
- LVTX 27.7K
- SRZN 28.0K
- Earning Date
- LVTX 03-19-2025
- SRZN 04-09-2025
- Dividend Yield
- LVTX N/A
- SRZN N/A
- EPS Growth
- LVTX N/A
- SRZN N/A
- EPS
- LVTX N/A
- SRZN N/A
- Revenue
- LVTX $7,345,000.00
- SRZN $10,000,000.00
- Revenue This Year
- LVTX $16.68
- SRZN N/A
- Revenue Next Year
- LVTX N/A
- SRZN N/A
- P/E Ratio
- LVTX N/A
- SRZN N/A
- Revenue Growth
- LVTX N/A
- SRZN N/A
- 52 Week Low
- LVTX $0.85
- SRZN $6.00
- 52 Week High
- LVTX $6.47
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- LVTX 46.74
- SRZN 49.20
- Support Level
- LVTX $0.85
- SRZN $11.25
- Resistance Level
- LVTX $0.98
- SRZN $12.55
- Average True Range (ATR)
- LVTX 0.05
- SRZN 0.97
- MACD
- LVTX 0.01
- SRZN 0.11
- Stochastic Oscillator
- LVTX 59.72
- SRZN 55.74
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).